In vivo findings of elevated CML levels concurrent with increased expression of Zeb2 in glomeruli and proteinuria in diabetic rats confirmed that CML mediated the effects under chronic DM conditions. The gene discussed is ZEB2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.